Tregs

Cell and gene therapy concept
#Cell and gene therapy #Eli Lilly #FDA #Novo Nordisk #Takeda #Tregs

A bright future for advanced therapies 

2025 was a difficult year for cell and gene therapies (CGTs), as multiple companies discontinued their cell therapy efforts, including Galapagos, Novo Nordisk and Takeda, despite significant financial losses as a result. The complexity and expense of manufacturing the treatments has meant that even when they are approved, the therapies do not always reach the relevant patients. This,… Read More

#Exclusive Content

#Nobel Prize #Sonoma Biotherapeutics #Tregs

Meet the researcher: Fred Ramsdell, Nobel winner 

Fred Ramsdell is Founder and Advisor, Sonoma Biotherapeutics and one of three co-winners of the 2025 Nobel Prize in Physiology or Medicine for the discovery of regulatory T cells (Tregs). He shares his career highlights with Diana Turner.  DT: Can you tell us what you’re working on at the moment or your most recent… Read More

#Exclusive Content #Opinion

Treg cells
#Kainova Therapeutics #Monotherapy #Tregs

Kainova Therapeutics doses first patient with cancer monotherapy 

Kainova Therapeutics has dosed the first patient with its Treg-depleting monotherapy.  The biopharmaceutical company dosed the patient in a Phase I/II clinical trial of DT-7012, a proprietary Treg depleting antiCCR8 monoclonal antibody, in patients with advanced solid tumours.  The study is evaluating DT7012 as monotherapy… Read More

#News

#ABPI #Clinical trials #Dementia #GLP-1 #Immune response #Neuroscience #NHS #Obesity #Oncology #Prostate cancer #T cell #Texas A&M University Health Science Center #Tregs #Weight loss

This week in Drug Discovery (23 – 27 March) 

News round-up for 23 – 27 March by Bruno Quinney, Content Team at DDW.  This week, obesity could be treated in other ways than through drugs suppressing appetite. Elsewhere, prostate cancer has been a central theme in cancer research.   The top stories:    Obesity… Read More

#News

Treg cells
#Dementia #Neuroscience #Tregs

Study supports Treg enhancement as dementia treatment

A research study led by Dr Alireza Faridar and Dr Stanley Appel at the Houston Methodist Neurological Institute has demonstrated the involvement of the peripheral immune system in the neuroinflammatory profile of frontotemporal dementia (FTD).  Dr Fred Grossman, Chief Medical Officer at sponsors Coya,… Read More

#Editor's Choice #News

Nobel prize winners
#Immune system #Karolinska Institutet #Nobel Prize #Tregs

Nobel prize awarded for regulatory T cells discovery

The Nobel Assembly at Karolinska Institutet has decided to award the 2025 Nobel Prize in Physiology or Medicine to three scientists “for their discoveries concerning peripheral immune tolerance”.  The winners are: Mary E Brunkow, Institute for Systems Biology, Seattle, USA; Fred Ramsdell, Sonoma Biotherapeutics, San Francisco, USA;… Read More

#Editor's Choice #News

Treg cells
#Amsterdam University Medical Centre #KRAS #Lung cancer #Oncology #The Francis Crick Institute #Tregs

Tregs block immune response in lung cancer, study finds

Researchers at the Francis Crick Institute, working with the Amsterdam University Medical Centre, have found that immune cells are held back from fighting lung tumours by another type of cell. Drugs that block a cancer-causing protein called KRAS-G12C are approved for use in lung cancer but… Read More

#Cancer Research #News